annual total liabilities:
$287.86M+$52.65M(+22.38%)Summary
- As of today (June 23, 2025), MDGL annual total liabilities is $287.86 million, with the most recent change of +$52.65 million (+22.38%) on December 31, 2024.
- During the last 3 years, MDGL annual total liabilities has risen by +$210.64 million (+272.76%).
- MDGL annual total liabilities is now at all-time high.
Performance
MDGL Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$285.99M-$1.87M(-0.65%)Summary
- As of today (June 23, 2025), MDGL quarterly total liabilities is $285.99 million, with the most recent change of -$1.87 million (-0.65%) on March 31, 2025.
- Over the past year, MDGL quarterly total liabilities has increased by +$54.47 million (+23.53%).
- MDGL quarterly total liabilities is now -3.42% below its all-time high of $296.11 million, reached on September 30, 2024.
Performance
MDGL quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
MDGL Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +22.4% | +23.5% |
| 3 y3 years | +272.8% | +271.8% |
| 5 y5 years | +1029.3% | +1000.7% |
MDGL Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +272.8% | -3.4% | +271.8% |
| 5 y | 5-year | at high | +1029.3% | -3.4% | +1000.7% |
| alltime | all time | at high | >+9999.0% | -3.4% | +8401.5% |
MDGL Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $285.99M(-0.7%) |
| Dec 2024 | $287.86M(+22.4%) | $287.86M(-2.8%) |
| Sep 2024 | - | $296.11M(+22.0%) |
| Jun 2024 | - | $242.67M(+4.8%) |
| Mar 2024 | - | $231.52M(-1.6%) |
| Dec 2023 | $235.21M(+42.4%) | $235.21M(+9.0%) |
| Sep 2023 | - | $215.72M(+8.4%) |
| Jun 2023 | - | $198.96M(+9.1%) |
| Mar 2023 | - | $182.31M(+10.4%) |
| Dec 2022 | $165.18M(+113.9%) | $165.18M(+11.6%) |
| Sep 2022 | - | $147.97M(+11.4%) |
| Jun 2022 | - | $132.86M(+72.7%) |
| Mar 2022 | - | $76.92M(-0.4%) |
| Dec 2021 | $77.22M(+64.2%) | $77.22M(+10.6%) |
| Sep 2021 | - | $69.82M(+21.8%) |
| Jun 2021 | - | $57.30M(+16.5%) |
| Mar 2021 | - | $49.18M(+4.6%) |
| Dec 2020 | $47.02M(+84.5%) | $47.02M(-5.8%) |
| Sep 2020 | - | $49.91M(+9.8%) |
| Jun 2020 | - | $45.47M(+75.0%) |
| Mar 2020 | - | $25.98M(+1.9%) |
| Dec 2019 | $25.49M(+201.9%) | $25.49M(+60.3%) |
| Sep 2019 | - | $15.90M(+23.9%) |
| Jun 2019 | - | $12.84M(+16.1%) |
| Mar 2019 | - | $11.05M(+30.9%) |
| Dec 2018 | $8.44M(-16.0%) | $8.44M(+27.1%) |
| Sep 2018 | - | $6.64M(+22.2%) |
| Jun 2018 | - | $5.44M(-13.6%) |
| Mar 2018 | - | $6.29M(-37.4%) |
| Dec 2017 | $10.05M(+109.5%) | $10.05M(+18.0%) |
| Sep 2017 | - | $8.52M(+32.4%) |
| Jun 2017 | - | $6.44M(+9.0%) |
| Mar 2017 | - | $5.91M(+23.0%) |
| Dec 2016 | $4.80M(-90.3%) | $4.80M(+22.6%) |
| Sep 2016 | - | $3.92M(+16.4%) |
| Jun 2016 | - | $3.36M(-61.1%) |
| Mar 2016 | - | $8.64M(-82.5%) |
| Dec 2015 | $49.28M | $49.28M(+60.8%) |
| Sep 2015 | - | $30.64M(-5.9%) |
| Jun 2015 | - | $32.56M(-2.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $33.25M(-6.4%) |
| Dec 2014 | $35.54M(-22.9%) | $35.54M(-11.0%) |
| Sep 2014 | - | $39.93M(-4.8%) |
| Jun 2014 | - | $41.95M(-4.6%) |
| Mar 2014 | - | $43.96M(-4.7%) |
| Dec 2013 | $46.11M(+65.0%) | $46.11M(+9.7%) |
| Sep 2013 | - | $42.05M(+9.3%) |
| Jun 2013 | - | $38.49M(+3.8%) |
| Mar 2013 | - | $37.10M(+32.7%) |
| Dec 2012 | $27.95M(+1.5%) | $27.95M(+9.9%) |
| Sep 2012 | - | $25.42M(-4.8%) |
| Jun 2012 | - | $26.70M(+2.4%) |
| Mar 2012 | - | $26.07M(-5.4%) |
| Dec 2011 | $27.55M(-9.9%) | $27.55M(-5.9%) |
| Sep 2011 | - | $29.29M(+0.4%) |
| Jun 2011 | - | $29.18M(-2.1%) |
| Mar 2011 | - | $29.82M(-2.5%) |
| Dec 2010 | $30.59M(+27.5%) | $30.59M(-3.3%) |
| Sep 2010 | - | $31.62M(+85.7%) |
| Jun 2010 | - | $17.03M(-11.1%) |
| Mar 2010 | - | $19.15M(-20.2%) |
| Dec 2009 | $24.00M(-84.6%) | $24.00M(-10.2%) |
| Sep 2009 | - | $26.73M(-83.0%) |
| Jun 2009 | - | $156.77M(-9.3%) |
| Mar 2009 | - | $172.88M(+10.8%) |
| Dec 2008 | $156.04M(+59.6%) | $156.04M(+24.5%) |
| Sep 2008 | - | $125.37M(+28.9%) |
| Jun 2008 | - | $97.27M(+1.4%) |
| Mar 2008 | - | $95.92M(-1.9%) |
| Dec 2007 | $97.75M(+72.9%) | $97.75M(+477.0%) |
| Sep 2007 | - | $16.94M(-11.5%) |
| Jun 2007 | - | $19.14M(+22.2%) |
| Mar 2007 | - | $15.66M(-72.3%) |
| Dec 2006 | $56.54M(+201.8%) | $56.54M(+1.0%) |
| Sep 2006 | - | $55.99M(+198.9%) |
| Dec 2005 | $18.73M(+33.2%) | $18.73M(+7.6%) |
| Mar 2005 | - | $17.41M |
| Dec 2004 | $14.06M(+302.3%) | - |
| Dec 2003 | $3.50M(>+9900.0%) | - |
| Dec 2001 | $29.00K | - |
FAQ
- What is Madrigal Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual total liabilities year-on-year change?
- What is Madrigal Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly total liabilities year-on-year change?
What is Madrigal Pharmaceuticals annual total liabilities?
The current annual total liabilities of MDGL is $287.86M
What is the all time high annual total liabilities for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual total liabilities is $287.86M
What is Madrigal Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, MDGL annual total liabilities has changed by +$52.65M (+22.38%)
What is Madrigal Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of MDGL is $285.99M
What is the all time high quarterly total liabilities for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly total liabilities is $296.11M
What is Madrigal Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, MDGL quarterly total liabilities has changed by +$54.47M (+23.53%)